+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchiolitis Obliterans Syndrome Market - Global Forecast 2025-2030- Product Image
Bronchiolitis Obliterans Syndrome Market - Global Forecast 2025-2030- Product Image
Sale

Bronchiolitis Obliterans Syndrome Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011463
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bronchiolitis Obliterans Syndrome Market is experiencing rapid transformation as healthcare providers and industry stakeholders focus on integrating advanced therapies, enhancing care delivery, and adapting to supply chain challenges. Decision-makers require current insights to navigate this dynamic environment and leverage new opportunities for sustainable growth.

Market Snapshot: Bronchiolitis Obliterans Syndrome Market

The Bronchiolitis Obliterans Syndrome Market grew from USD 73.25 million in 2024 to USD 79.43 million in 2025. It is expected to continue growing at a CAGR of 8.36%, reaching USD 118.64 million by 2030. Growth is underpinned by advancements in drug formulations, evolving therapeutic strategies, and increased adoption of digital health platforms enhancing disease management across diverse settings.

Scope & Segmentation

  • Drug Class: Includes formulations and subgroups such as corticosteroids (inhaled, systemic), immunosuppressants (antimetabolites, calcineurin inhibitors), and macrolides (azithromycin, clarithromycin).
  • Procedure Type: Covers interventions such as bronchoscopy, lung transplantation (single, double), and pulmonary rehabilitation with both inpatient and outpatient modalities.
  • Delivery Mode: Examines inhalation (inhalers, nebulizers), intravenous (bolus, infusion), and oral (capsules, tablets) therapies.
  • End User: Profiles ambulatory surgery centers (hospital-owned, independent), private and public hospitals, pulmonology clinics, and transplant centers.
  • Distribution Channel: Considers pathways like hospital pharmacies (inpatient, outpatient), online pharmacies (over-the-counter, prescription), and retail outlets (chain, independent).
  • Regional Coverage: Encompasses Americas (including U.S. states and major LATAM markets), Europe, Middle East & Africa (with focus on regulatory diversity and infrastructure), and Asia-Pacific (with key attention to local manufacturing and digital health integration).
  • Company Profiles: Includes leading companies such as Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Astellas Pharma Inc., Takeda, GlaxoSmithKline, and others.

Key Takeaways for Healthcare Stakeholders

  • Clinical management is shifting toward holistic care models, with increased focus on early diagnosis supported by evolving biomarkers and digital monitoring tools.
  • Integration of advanced immunomodulatory therapies and new-combination regimens enables improved targeting of inflammatory pathways and fibrotic progression mitigation.
  • Partnerships between pharmaceutical, biotech, and technology firms are advancing precision medicine protocols and strengthening patient engagement strategies in routine practice.
  • Healthcare systems benefit from evolving clinical guidelines and real-world evidence that refine dosing, support regulatory acceleration, and enable adaptive treatment pathways.
  • Strategic adjustments across supply and distribution chains, especially dual sourcing and localized warehousing, are helping stabilize therapy delivery amid global disruptions.

Tariff Impact on Supply Chain and Cost Structure

In early 2025, new United States tariff policies affected the procurement and distribution of both pharmaceutical ingredients and medical devices required for bronchiolitis obliterans syndrome. Tariff-driven cost increases prompted manufacturers to diversify sourcing, while healthcare providers sought margin relief through bulk purchasing and shipment consolidation. Collaborative action across the value chain, including negotiations for tariff exemptions and enhanced stockpiling, is strengthening resilience and safeguarding patient access.

Research Methodology & Data Sources

This research combines systematic secondary analysis—including peer-reviewed literature and regulatory filings—with primary interviews involving clinicians, reimbursement analysts, and supply chain executives. Qualitative and quantitative methodologies were employed, with expert validation ensuring consistent, reliable findings throughout the report development.

Why This Report Matters

  • Offers actionable analysis for senior leaders evaluating evolving care models and supply chain strategies within the bronchiolitis obliterans syndrome landscape.
  • Supports resource optimization by highlighting segmentation, innovation pipelines, and evidence-based interventions aligned to regional and regulatory priorities.

Conclusion

The bronchiolitis obliterans syndrome market is advancing through therapeutic innovation, collaborative care models, and adaptive supply strategies. Stakeholders equipped with this knowledge can support better clinical outcomes and robust operational resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of targeted anti-fibrotic therapies for managing post-transplant bronchiolitis obliterans syndrome
5.2. Expansion of home spirometry and remote monitoring solutions for early detection of bronchiolitis obliterans syndrome
5.3. Advancement of inhaled anti-inflammatory biologics in clinical pipeline for bronchiolitis obliterans syndrome treatment strategies
5.4. Collaborative partnerships between pharmaceutical and diagnostic firms to validate novel bronchiolitis obliterans syndrome biomarkers
5.5. Growing investment in patient registries and real-world evidence platforms to track bronchiolitis obliterans syndrome outcomes and disease progression
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bronchiolitis Obliterans Syndrome Market, by Drug Class
8.1. Introduction
8.2. Corticosteroids
8.2.1. Inhaled
8.2.2. Systemic
8.3. Immunosuppressants
8.3.1. Antimetabolites
8.3.2. Calcineurin Inhibitors
8.4. Macrolides
8.4.1. Azithromycin
8.4.2. Clarithromycin
9. Bronchiolitis Obliterans Syndrome Market, by Procedure Type
9.1. Introduction
9.2. Bronchoscopy
9.3. Lung Transplantation
9.3.1. Double Lung
9.3.2. Single Lung
9.4. Pulmonary Rehabilitation
9.4.1. Inpatient
9.4.2. Outpatient
10. Bronchiolitis Obliterans Syndrome Market, by Delivery Mode
10.1. Introduction
10.2. Inhalation
10.2.1. Inhalers
10.2.2. Nebulizers
10.3. Intravenous
10.3.1. Bolus
10.3.2. Infusion
10.4. Oral
10.4.1. Capsules
10.4.2. Tablets
11. Bronchiolitis Obliterans Syndrome Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.2.1. Hospital Owned
11.2.2. Independent
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Specialty Clinics
11.4.1. Pulmonology Clinics
11.4.2. Transplant Centers
12. Bronchiolitis Obliterans Syndrome Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.2.1. Inpatient
12.2.2. Outpatient
12.3. Online Pharmacies
12.3.1. Otc E Pharmacies
12.3.2. Prescription E Pharmacies
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. Americas Bronchiolitis Obliterans Syndrome Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bronchiolitis Obliterans Syndrome Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bronchiolitis Obliterans Syndrome Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Pfizer Inc.
16.3.3. F. Hoffmann-La Roche Ltd
16.3.4. Astellas Pharma Inc.
16.3.5. Mallinckrodt plc
16.3.6. Bristol-Myers Squibb Company
16.3.7. Sanofi S.A.
16.3.8. Takeda Pharmaceutical Company Limited
16.3.9. Merck & Co., Inc.
16.3.10. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRONCHIOLITIS OBLITERANS SYNDROME MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRONCHIOLITIS OBLITERANS SYNDROME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRONCHIOLITIS OBLITERANS SYNDROME MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRONCHIOLITIS OBLITERANS SYNDROME MARKET: RESEARCHAI
FIGURE 26. BRONCHIOLITIS OBLITERANS SYNDROME MARKET: RESEARCHSTATISTICS
FIGURE 27. BRONCHIOLITIS OBLITERANS SYNDROME MARKET: RESEARCHCONTACTS
FIGURE 28. BRONCHIOLITIS OBLITERANS SYNDROME MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRONCHIOLITIS OBLITERANS SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DOUBLE LUNG, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DOUBLE LUNG, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SINGLE LUNG, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SINGLE LUNG, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BOLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BOLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OTC E PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY OTC E PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PRESCRIPTION E PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PRESCRIPTION E PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 214. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 215. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 216. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 217. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 218. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 219. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 220. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 221. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2018-2024 (USD MILLION)
TABLE 226. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2025-2030 (USD MILLION)
TABLE 227. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 228. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 229. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 232. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 233. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 234. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 235. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 238. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 239. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. CANADA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 272. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 273. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. MEXICO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bronchiolitis Obliterans Syndrome market report include:
  • Novartis AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Astellas Pharma Inc.
  • Mallinckrodt plc
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Merck & Co., Inc.
  • GlaxoSmithKline plc

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 79.43 Million
Forecasted Market Value ( USD ) by 2030 $ 118.64 Million
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bronchiolitis Obliterans Syndrome Global Market Report 2025 - Product Image

Bronchiolitis Obliterans Syndrome Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Bronchitis Treatment Market Report 2025 - Product Image

Bronchitis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Acute Respiratory Distress Syndrome Market - Global Forecast to 2030 - Product Image

Acute Respiratory Distress Syndrome Market - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report - Product Image

Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.